用富途牛牛查看Fisher & Paykel Healthcare Corp Ltd (FPH)的股票价格、新闻、历史走势图、分析师评级、财务信息和行情。使用富途牛牛免佣金股票交易App进行交易。
The article offers information on Fisher & Paykel Healthcare Ltd., one of the exhibitors at the British Thoracic Society's winter meeting in London, England in December 2008. Fisher provides the SleepStyle family of auto and fixed pressure dev...
Latest Fisher & Paykel Healthcare Corporation Ltd (FPH:DEU) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
澳洲医疗保健公司Fisher & Paykel Healthcare已将其2024财年的盈利指导上调至2.6亿新西兰元(2.391亿澳元)-2.65亿新西兰元的范围。 此次预测高于公司之前对税后净利润的预测,之前的范围是2.5亿新西兰元-2.6亿新西兰元。 该公司现在预计营业收入将达到约17.3亿新西兰元(假设新西兰元/美元汇率为61美分),高于此前的预测,即...
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare se...
费雪派克医疗保健(广州)有限公司,是费雪派克医疗保健公司(Fisher& Paykel Healthcare)在中国成立的全资附属子公司,业务范围是为中国大陆市场提供进口的费雪派克医疗保健公司(Fisher & Paykel Healthcare)全系列产品,主要包括湿化器系统,呼吸管路及相关耗材,婴儿正压呼吸系统,婴儿抢救台,复苏器以及治疗阻塞性睡眠呼吸暂停症...
View the most recent data and latest information on option chains for Fisher & Paykel Healthcare Corporation Limited (FSPKF) at Nasdaq.com.
公司名称Fisher & Paykel Healthcare Corp Ltd 成立日期1934 所属市场ASX 员工数量7168 年结日03-31 公司地址15 Maurice Paykel Place East Tamaki 城市Auckland 国家NZL 邮编2013 电话+64 95740100 网址https://www.fphcare.com 股份登记处LINK MARKET SERVICES LIMITED LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW...
费雪派克医疗保健有限公司(Fisher&PaykelHealthcare)是阻塞性睡眠呼吸暂停综合症(OSA)治疗领域领先的创新者。我们将用于重症监护病房(ICU)加温湿化器的精湛技术带入这一市场,用在持续气道正压通气(CPAP)治疗。我们的目的是为了提高患者的舒适度和治疗顺应性,在此之前患者对治疗的耐受性很低。此后,加温湿化技术CPAP治疗...
Discover all the products from Fisher & Paykel Healthcare and see a list of their distributors. Contact the manufacturer directly for a quote.